A phase I study of the novel immunotoxin, MT-5111, in subjects (subj) with HER-2
- This topic has 0 replies, 1 voice, and was last updated 3 years, 11 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
A phase I study of the novel immunotoxin, MT-5111, in subjects (subj) with HER-2 positive tumors: Interim results.
https://meetinglibrary.asco.org/record/189043/abstract
Viewing 1 post (of 1 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.